BG36199A3 - Method for preparing derivatives of 3- (1- piperidinylalkyl)- 4h- pyrido (1, 2- a) pyrimidin- 4- on - Google Patents

Method for preparing derivatives of 3- (1- piperidinylalkyl)- 4h- pyrido (1, 2- a) pyrimidin- 4- on

Info

Publication number
BG36199A3
BG36199A3 BG051433A BG5143381A BG36199A3 BG 36199 A3 BG36199 A3 BG 36199A3 BG 051433 A BG051433 A BG 051433A BG 5143381 A BG5143381 A BG 5143381A BG 36199 A3 BG36199 A3 BG 36199A3
Authority
BG
Bulgaria
Prior art keywords
piperidinylalkyl
pyrido
pyrimidin
preparing derivatives
preparing
Prior art date
Application number
BG051433A
Other languages
Bulgarian (bg)
English (en)
Inventor
Ludo Kennis
Josephus Mertens
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of BG36199A3 publication Critical patent/BG36199A3/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/30—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/34—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
BG051433A 1980-03-28 1981-03-27 Method for preparing derivatives of 3- (1- piperidinylalkyl)- 4h- pyrido (1, 2- a) pyrimidin- 4- on BG36199A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13484580A 1980-03-28 1980-03-28
US06/191,632 US4342870A (en) 1980-03-28 1980-09-29 Novel 3-(1-piperidinylalkyl)-4H-pyrido[1,2-a]pyrimidin-4-one derivatives

Publications (1)

Publication Number Publication Date
BG36199A3 true BG36199A3 (en) 1984-09-14

Family

ID=26832744

Family Applications (1)

Application Number Title Priority Date Filing Date
BG051433A BG36199A3 (en) 1980-03-28 1981-03-27 Method for preparing derivatives of 3- (1- piperidinylalkyl)- 4h- pyrido (1, 2- a) pyrimidin- 4- on

Country Status (22)

Country Link
US (1) US4342870A (el)
EP (1) EP0037265B1 (el)
AU (1) AU537700B2 (el)
BG (1) BG36199A3 (el)
CA (1) CA1163994A (el)
CS (1) CS256366B2 (el)
DE (1) DE3168433D1 (el)
DK (1) DK159390C (el)
ES (1) ES500814A0 (el)
FI (1) FI71737C (el)
GR (1) GR72488B (el)
HU (1) HU187329B (el)
IE (1) IE51319B1 (el)
IL (1) IL62494A (el)
MA (1) MA19107A1 (el)
NO (1) NO156752C (el)
NZ (1) NZ196522A (el)
PH (1) PH16530A (el)
PT (1) PT72740B (el)
RO (1) RO82508A (el)
SU (1) SU1068037A3 (el)
YU (1) YU43010B (el)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4443451A (en) 1981-07-15 1984-04-17 Janssen Pharmaceutica N.V. Bicyclic pyrimidin-5-one derivatives
US4548938A (en) * 1981-07-15 1985-10-22 Janssen Pharmaceutica N.V. 5-H-1,3,4-thiadiazolo[3,2-a]pyrimidin-5-one compounds
US4355037A (en) * 1981-11-12 1982-10-19 Hoechst-Roussel Pharmaceuticals 3-(4-Piperidyl)-1,2-benzisoxales
US4485107A (en) * 1982-11-01 1984-11-27 Janssen Pharmaceutica N.V. [[Bis(aryl)methylene]-1-piperidinyl]alkyl-pyrimidinones
US4581171A (en) * 1983-07-27 1986-04-08 Janssen Pharmaceutica, N.V. [[Bis(aryl)methylene]-1-piperidinyl]alkyl-pyrimidinones useful for treating psychotropic disorders
US4695569A (en) * 1983-11-30 1987-09-22 Janssen Pharmaceutica N.V. Bicyclic heterocyclyl containing N-(bicyclic heterocyclyl)-4-piperidinamines
US4888426A (en) * 1983-11-30 1989-12-19 Janssen Pharmaceutica N.V. 1-(5-methyl-furan-2-ylmethyl)-N-(4-piperidinyl)imidazo [4,5-6]pyridine-2-amine
PH23995A (en) * 1984-01-09 1990-02-09 Janssen Pharmaceutica Nv 4((bicycle heterocyclyl)-methyl and hetero)piperidines
US4548939A (en) * 1984-10-01 1985-10-22 Janssen Pharmaceutica N. V. 1H-Indol-3-yl containing 1,3-dimethyl-1H-purine-2,6-diones
US4804663A (en) * 1985-03-27 1989-02-14 Janssen Pharmaceutica N.V. 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles
ES2094718T3 (es) * 1986-09-22 1997-02-01 Janssen Pharmaceutica Nv Antagonistas de la serotonine para el tratamiento de heridas.
IL90879A0 (en) * 1988-09-02 1990-02-09 Janssen Pharmaceutica Nv 3-piperidinyl-indazole derivatives,their preparation and antihypertensive compositions containing them
CA2000786C (en) * 1988-11-07 1999-01-26 Cornelus G. M. Janssen 3-piperidinyl-1,2-benzisoxazoles
HU207310B (en) * 1988-12-02 1993-03-29 Pfizer Process for producing aryl-piperidine derivatives
AU5660190A (en) * 1989-03-23 1990-10-22 Mallinckrodt, Inc. Radioactive iodine- or bromine labelled piperidine compound as well as method of preparing same and composition comprising said compound
DE4138756A1 (de) * 1991-11-26 1993-05-27 Troponwerke Gmbh & Co Kg Kombination mit neuroprotektiver wirkung
US5266571A (en) * 1992-01-09 1993-11-30 Amer Moh Samir Treatment of hemorrhoids with 5-HT2 antagonists
NZ249286A (en) * 1992-02-13 1996-02-27 Merrell Dow Pharma Piperidine-4-ylmethyl thiophene and thiazole derivatives and pharmaceutical compositions
ES2159526T3 (es) * 1992-07-13 2001-10-16 Janssen Pharmaceutica Nv Nuevos derivados de 4-(3-benzofuranil)piperidinilo y 4-(3-benzotienil)piperidinilo y composiciones farmaceuticas que los contienen.
WO1995013814A1 (en) 1993-11-19 1995-05-26 Janssen Pharmaceutica N.V. Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles
ES2085234B1 (es) * 1994-02-24 1997-01-16 Vita Invest Sa Agente activo sobre el sistema nervioso central, procedimiento para su preparacion y composiciones farmaceuticas que lo contienen.
TW421649B (en) * 1995-01-31 2001-02-11 Janssen Pharmaceutica Nv 4-(1H-indol-1yl)-1-piperidinyl derivatives
US5753664A (en) * 1995-03-16 1998-05-19 Takeda Chemical Industries, Ltd. Heterocyclic compounds, their production and use
WO2004043923A1 (en) * 2002-11-13 2004-05-27 Synthon B.V. Process for making risperidone and intermediates therefor
WO2004094415A1 (en) * 2003-04-22 2004-11-04 Synthon B.V. Risperidone monohydrochloride
CN101970427A (zh) 2008-02-29 2011-02-09 Vm生物医药公司 治疗疼痛症状及其它失调的方法
AU2013216870B2 (en) 2012-02-10 2017-07-20 F. Hoffmann-La Roche Ag Compounds for treating spinal muscular atrophy
US9371336B2 (en) 2012-03-01 2016-06-21 Ptc Therapeutics, Inc. Compounds for treating spinal muscular atrophy
EA028382B1 (ru) 2012-03-23 2017-11-30 ПиТиСи ТЕРАПЬЮТИКС, ИНК. Соединения для лечения спинальной мышечной атрофии
EP2970188A4 (en) * 2013-03-15 2016-10-19 Vm Therapeutics Llc NOVEL CRYSTALLINE FORMS
US10195202B2 (en) 2013-12-19 2019-02-05 Ptc Therapeutics, Inc. Methods for modulating the amount of RNA transcripts
US10668171B2 (en) 2015-05-30 2020-06-02 Ptc Therapeutics, Inc. Methods for modulating RNA splicing
IL281633B (en) 2015-12-10 2022-07-01 Ptc Therapeutics Inc Methods for treating Huntington's disease
JP2019535789A (ja) 2016-11-28 2019-12-12 ピーティーシー セラピューティクス，インコーポレーテッド Ｒｎａスプライシングを調節する方法
EA201992878A1 (ru) 2017-06-05 2020-05-08 ПиТиСи ТЕРАПЬЮТИКС, ИНК. Соединения для лечения болезни хантингтона
BR112019026508A2 (pt) 2017-06-14 2020-07-14 Ptc Therapeutics, Inc. métodos para modificar o splicing do rna
US11382918B2 (en) 2017-06-28 2022-07-12 Ptc Therapeutics, Inc. Methods for treating Huntington's Disease
CN111163838B (zh) 2017-06-28 2023-03-28 Ptc医疗公司 用于治疗亨廷顿氏病的方法
EA202092001A1 (ru) 2018-03-27 2021-01-29 ПиТиСи ТЕРАПЬЮТИКС, ИНК. Соединения для лечения болезни гентингтона
WO2020005882A1 (en) 2018-06-27 2020-01-02 Ptc Therapeutics, Inc. Heteroaryl compounds for treating huntington's disease
MX2020014098A (es) 2018-06-27 2021-05-27 Ptc Therapeutics Inc Compuestos heterocíclicos y de heteroarilo para tratar la enfermedad de huntington.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3412094A (en) * 1967-06-21 1968-11-19 Searle & Co 5-alkyl-2-amino-4-azido-6-phenylpyrimidines and congeners
US3960863A (en) * 1974-06-25 1976-06-01 Sankyo Company Limited Pyrido[1,2-a]pyrimidinone derivatives
JPS5146497A (en) * 1974-10-19 1976-04-20 Masato Aiura Hobuban
JPS525795A (en) * 1975-06-28 1977-01-17 Sankyo Co Ltd Preparation of tetrahydro pyridopyrimidinone derivatives
HU173438B (hu) * 1975-11-27 1979-05-28 Chinoin Gyogyszer Es Vegyeszet Sposob poluchenija novykh proizvodnykh 4-okso-1,6,7,8-/tetragidro-4h-pirido/1,2/pirimidina s zaderzhivajuhhejj vozgoranie aktivnot'ju i protivosvertivajuhhem effektom

Also Published As

Publication number Publication date
EP0037265A1 (en) 1981-10-07
CA1163994A (en) 1984-03-20
DE3168433D1 (de) 1985-03-07
HU187329B (en) 1985-12-28
GR72488B (el) 1983-11-14
IL62494A0 (en) 1981-05-20
IE810706L (en) 1981-09-28
NO156752B (no) 1987-08-10
NZ196522A (en) 1985-10-11
ES8300763A1 (es) 1982-11-01
YU81081A (en) 1983-12-31
IE51319B1 (en) 1986-12-10
NO156752C (no) 1987-11-18
PH16530A (en) 1983-11-10
AU6842981A (en) 1981-10-01
DK159390C (da) 1991-03-04
AU537700B2 (en) 1984-07-05
PT72740B (en) 1982-11-16
DK138281A (da) 1981-09-29
PT72740A (en) 1981-04-01
YU43010B (en) 1989-02-28
EP0037265B1 (en) 1985-01-23
RO82508A (ro) 1983-09-26
FI810956L (fi) 1981-09-29
FI71737C (fi) 1987-02-09
FI71737B (fi) 1986-10-31
CS256366B2 (en) 1988-04-15
SU1068037A3 (ru) 1984-01-15
US4342870A (en) 1982-08-03
DK159390B (da) 1990-10-08
NO811058L (no) 1981-09-29
ES500814A0 (es) 1982-11-01
IL62494A (en) 1984-08-31
MA19107A1 (fr) 1981-10-01
RO82508B (ro) 1983-08-30

Similar Documents

Publication Publication Date Title
BG36199A3 (en) Method for preparing derivatives of 3- (1- piperidinylalkyl)- 4h- pyrido (1, 2- a) pyrimidin- 4- on
BG40655A3 (en) Method for preparing n- (bi heterocyclic)- 4- piperidineamines
BG37995A3 (en) Method for preparing derivatives of 2- cyanbenzimidazol
BG38333A3 (en) Method for preparing substituted phenylcarboxyoximes
BG35327A3 (en) Method for preparing pyrodoxine derivatives
BG35328A3 (en) Method for preparing imidodisulphamidic derivatives
BG38334A3 (en) Method for preparing pyrolidinic derivatives
BG34908A3 (en) Method for preparing d- 6- n- propylergolines
BG35330A3 (en) Method for preparing 3- iodine- methylcephalosporines
BG28712A3 (en) Method of obtaining of substituated in 11- a position 5,11- dihydro- 6h- pyrido (2,3-b) (1,4) benzodiazepine- 6- ons
BG36348A3 (en) Method for preparing thienopyridinon derivatives
BG41822A3 (en) Method for preparing pyridyl derivatives
BG41126A3 (en) Method for preparing benzamides
BG34907A3 (en) Method for preparing benzodiazepine compounds
BG38489A3 (en) Method for preparing oxazophosphorine- 6, 4- thiolcalsulphonic acids and their neutral salts
BG28711A3 (en) Method of obtaining of substituated in 11- a position 5,11- dihydro-6h- pyrido (2,3- b) (1,4) benzodiazepine- 6- ons
BG28713A3 (en) Method of obtaining of 5,11- dihydro- 6h- pyrido (2,3- b) (1,4) benzodiazepine- 6- ons
BG35746A3 (en) Method for preparing 1- cyclohexenylmethylpyrolidines
BG40803A3 (en) Method for preparing arylcyclobutylalkylaminic derivatives
BG35464A3 (en) Method preparing fluorene derivatives
BG40147A3 (en) Method for preparing heterocyclic compounds
BG38638A3 (en) Method for preparing arylcyclobutyl- aminoderivatives
BG36935A3 (en) Method for preparing benzodiazepine compounds
BG35897A3 (en) Method for preparing 5- (dihydroxy- phenoxy)- 1h- tetrazoles
BG36495A3 (en) Method for preparing 4- quinolic derivatives